Mitochondrial dysfunction in Alzheimer's disease: connecting pathophysiology with neuroimaging

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing cognitive decline.
• Mitochondrial dysfunction, marked by impaired energy metabolism and oxidative stress, is increasingly recognized as a central factor in AD pathogenesis.
• This dysfunction interacts with amyloid-beta (Aβ) and phosphorylated tau (p-tau) to create a detrimental cycle.

Purpose of the Study:

• To systematically review the mechanisms of mitochondrial dysfunction in Alzheimer's disease.
• To highlight the role of advanced neuroimaging technologies in detecting mitochondrial abnormalities and metabolic disturbances in AD.
• To evaluate the potential of integrating mitochondrial research with neuroimaging for AD diagnosis and treatment.

Main Methods:

• Systematic review of existing literature on mitochondrial dysfunction in AD.
• Exploration of recent advancements in neuroimaging techniques, including Positron Emission Tomography (PET), Magnetic Resonance Spectroscopy (MRS), and Susceptibility-Weighted Imaging (SWI).
• Analysis of how these imaging modalities can assess mitochondrial metabolism, oxidative stress, iron deposition, and neural network integrity in vivo.

Main Results:

• Mitochondrial dysfunction contributes significantly to neurodegeneration in Alzheimer's disease.
• Neuroimaging techniques like PET, MRS, and SWI offer powerful tools for visualizing and quantifying mitochondrial abnormalities and metabolic deficits associated with AD.
• These methods allow for in vivo assessment of key pathological markers and network integrity.

Conclusions:

• Mitochondrial dysfunction is a critical player in the complex pathology of Alzheimer's disease.
• Advanced neuroimaging provides novel avenues for early AD diagnosis, patient stratification, and objective assessment of therapeutic interventions.
• The synergy between understanding mitochondrial mechanisms and utilizing sophisticated neuroimaging holds significant promise for both fundamental research and clinical applications in AD.